Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orthopaedics march on and cardiovascular keeps pace - Zimmer and Boston sales up a fifth after nine months

This article was originally published in Clinica

Executive Summary

UK discovery instrumentation and imaging agent group Amersham, which is to be acquired by General Electric, said its Amersham Health diagnostics division had sales of £235m ($398m) in the third quarter, up by 6% excluding currency fluctuation effects. Medical diagnostic products excluding Japan grew by 11% with patented products up by 19%. The group said its Visipaque non-ionic X-ray contrast media "continued excellent growth". CEO Sir William Castell said the company was on track to meet its full-year targets.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065147

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel